Mount Sinai Reveals Psychedelic Drugs' Therapeutic Potential
Audrey Warren, PhD, discusses her study regarding the complex mechanisms by which a class of psychedelic drugs binds to and activates serotonin receptors to produce potential therapeutic effects in patients with neuropsychiatric disorders such as depression and anxiety. Learn more
Mount Sinai Launches the Marilyn Monroe Mental Health for the Arts Program
Apr 30, 2026 View All Press Releases
A Promising Study Suggests a Blood Test Could Spot Alzheimer’s Early in Progression
Apr 21, 2026 View All Press Releases
New Research Reveals Autism Risk Genes Are Shared Across Ancestries
Mar 30, 2026 View All Press Releases
Icahn School of Medicine at Mount Sinai Remains Among Top Institutions for NIH Funding
Mar 05, 2026 View All Press Releases